Chapter/Section Purchase

1 Study Coverage
1.1 Polymer Drug Conjugates Product Introduction
1.2 Market by Type
1.2.1 Global Polymer Drug Conjugates Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Polymer-Dox Conjugates
1.2.3 Polymer-Paclitaxel Conjugates
1.2.4 Polymer-Camptothecin Conjugates
1.2.5 Polymer-Platinate Conjugates
1.3 Market by Application
1.3.1 Global Polymer Drug Conjugates Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Cancer Treatment
1.3.3 Leukmia
1.3.4 Hepatitis
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Polymer Drug Conjugates Sales Estimates and Forecasts 2017-2028
2.2 Global Polymer Drug Conjugates Revenue Estimates and Forecasts 2017-2028
2.3 Global Polymer Drug Conjugates Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global Polymer Drug Conjugates Sales by Region
2.4.1 Global Polymer Drug Conjugates Sales by Region (2017-2022)
2.4.2 Global Sales Polymer Drug Conjugates by Region (2023-2028)
2.5 Global Polymer Drug Conjugates Revenue by Region
2.5.1 Global Polymer Drug Conjugates Revenue by Region (2017-2022)
2.5.2 Global Polymer Drug Conjugates Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Polymer Drug Conjugates Sales by Manufacturers
3.1.1 Global Top Polymer Drug Conjugates Manufacturers by Sales (2017-2022)
3.1.2 Global Polymer Drug Conjugates Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Polymer Drug Conjugates in 2021
3.2 Global Polymer Drug Conjugates Revenue by Manufacturers
3.2.1 Global Polymer Drug Conjugates Revenue by Manufacturers (2017-2022)
3.2.2 Global Polymer Drug Conjugates Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by Polymer Drug Conjugates Revenue in 2021
3.3 Global Polymer Drug Conjugates Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Polymer Drug Conjugates Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Polymer Drug Conjugates Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Polymer Drug Conjugates Sales by Type
4.1.1 Global Polymer Drug Conjugates Historical Sales by Type (2017-2022)
4.1.2 Global Polymer Drug Conjugates Forecasted Sales by Type (2023-2028)
4.1.3 Global Polymer Drug Conjugates Sales Market Share by Type (2017-2028)
4.2 Global Polymer Drug Conjugates Revenue by Type
4.2.1 Global Polymer Drug Conjugates Historical Revenue by Type (2017-2022)
4.2.2 Global Polymer Drug Conjugates Forecasted Revenue by Type (2023-2028)
4.2.3 Global Polymer Drug Conjugates Revenue Market Share by Type (2017-2028)
4.3 Global Polymer Drug Conjugates Price by Type
4.3.1 Global Polymer Drug Conjugates Price by Type (2017-2022)
4.3.2 Global Polymer Drug Conjugates Price Forecast by Type (2023-2028)
5 Market Size by Application
5.1 Global Polymer Drug Conjugates Sales by Application
5.1.1 Global Polymer Drug Conjugates Historical Sales by Application (2017-2022)
5.1.2 Global Polymer Drug Conjugates Forecasted Sales by Application (2023-2028)
5.1.3 Global Polymer Drug Conjugates Sales Market Share by Application (2017-2028)
5.2 Global Polymer Drug Conjugates Revenue by Application
5.2.1 Global Polymer Drug Conjugates Historical Revenue by Application (2017-2022)
5.2.2 Global Polymer Drug Conjugates Forecasted Revenue by Application (2023-2028)
5.2.3 Global Polymer Drug Conjugates Revenue Market Share by Application (2017-2028)
5.3 Global Polymer Drug Conjugates Price by Application
5.3.1 Global Polymer Drug Conjugates Price by Application (2017-2022)
5.3.2 Global Polymer Drug Conjugates Price Forecast by Application (2023-2028)
6 North America
6.1 North America Polymer Drug Conjugates Market Size by Type
6.1.1 North America Polymer Drug Conjugates Sales by Type (2017-2028)
6.1.2 North America Polymer Drug Conjugates Revenue by Type (2017-2028)
6.2 North America Polymer Drug Conjugates Market Size by Application
6.2.1 North America Polymer Drug Conjugates Sales by Application (2017-2028)
6.2.2 North America Polymer Drug Conjugates Revenue by Application (2017-2028)
6.3 North America Polymer Drug Conjugates Market Size by Country
6.3.1 North America Polymer Drug Conjugates Sales by Country (2017-2028)
6.3.2 North America Polymer Drug Conjugates Revenue by Country (2017-2028)
6.3.3 U.S.
6.3.4 Canada
7 Europe
7.1 Europe Polymer Drug Conjugates Market Size by Type
7.1.1 Europe Polymer Drug Conjugates Sales by Type (2017-2028)
7.1.2 Europe Polymer Drug Conjugates Revenue by Type (2017-2028)
7.2 Europe Polymer Drug Conjugates Market Size by Application
7.2.1 Europe Polymer Drug Conjugates Sales by Application (2017-2028)
7.2.2 Europe Polymer Drug Conjugates Revenue by Application (2017-2028)
7.3 Europe Polymer Drug Conjugates Market Size by Country
7.3.1 Europe Polymer Drug Conjugates Sales by Country (2017-2028)
7.3.2 Europe Polymer Drug Conjugates Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Polymer Drug Conjugates Market Size by Type
8.1.1 Asia Pacific Polymer Drug Conjugates Sales by Type (2017-2028)
8.1.2 Asia Pacific Polymer Drug Conjugates Revenue by Type (2017-2028)
8.2 Asia Pacific Polymer Drug Conjugates Market Size by Application
8.2.1 Asia Pacific Polymer Drug Conjugates Sales by Application (2017-2028)
8.2.2 Asia Pacific Polymer Drug Conjugates Revenue by Application (2017-2028)
8.3 Asia Pacific Polymer Drug Conjugates Market Size by Region
8.3.1 Asia Pacific Polymer Drug Conjugates Sales by Region (2017-2028)
8.3.2 Asia Pacific Polymer Drug Conjugates Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
8.3.12 Philippines
9 Latin America
9.1 Latin America Polymer Drug Conjugates Market Size by Type
9.1.1 Latin America Polymer Drug Conjugates Sales by Type (2017-2028)
9.1.2 Latin America Polymer Drug Conjugates Revenue by Type (2017-2028)
9.2 Latin America Polymer Drug Conjugates Market Size by Application
9.2.1 Latin America Polymer Drug Conjugates Sales by Application (2017-2028)
9.2.2 Latin America Polymer Drug Conjugates Revenue by Application (2017-2028)
9.3 Latin America Polymer Drug Conjugates Market Size by Country
9.3.1 Latin America Polymer Drug Conjugates Sales by Country (2017-2028)
9.3.2 Latin America Polymer Drug Conjugates Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Polymer Drug Conjugates Market Size by Type
10.1.1 Middle East and Africa Polymer Drug Conjugates Sales by Type (2017-2028)
10.1.2 Middle East and Africa Polymer Drug Conjugates Revenue by Type (2017-2028)
10.2 Middle East and Africa Polymer Drug Conjugates Market Size by Application
10.2.1 Middle East and Africa Polymer Drug Conjugates Sales by Application (2017-2028)
10.2.2 Middle East and Africa Polymer Drug Conjugates Revenue by Application (2017-2028)
10.3 Middle East and Africa Polymer Drug Conjugates Market Size by Country
10.3.1 Middle East and Africa Polymer Drug Conjugates Sales by Country (2017-2028)
10.3.2 Middle East and Africa Polymer Drug Conjugates Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 3S Bio
11.1.1 3S Bio Corporation Information
11.1.2 3S Bio Overview
11.1.3 3S Bio Polymer Drug Conjugates Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 3S Bio Polymer Drug Conjugates Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 3S Bio Recent Developments
11.2 Abeona Therapeutics
11.2.1 Abeona Therapeutics Corporation Information
11.2.2 Abeona Therapeutics Overview
11.2.3 Abeona Therapeutics Polymer Drug Conjugates Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 Abeona Therapeutics Polymer Drug Conjugates Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Abeona Therapeutics Recent Developments
11.3 Abramson Cancer Center
11.3.1 Abramson Cancer Center Corporation Information
11.3.2 Abramson Cancer Center Overview
11.3.3 Abramson Cancer Center Polymer Drug Conjugates Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 Abramson Cancer Center Polymer Drug Conjugates Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Abramson Cancer Center Recent Developments
11.4 Access Pharmaceuticals
11.4.1 Access Pharmaceuticals Corporation Information
11.4.2 Access Pharmaceuticals Overview
11.4.3 Access Pharmaceuticals Polymer Drug Conjugates Sales, Price, Revenue and Gross Margin (2017-2022)
11.4.4 Access Pharmaceuticals Polymer Drug Conjugates Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Access Pharmaceuticals Recent Developments
11.5 Adama
11.5.1 Adama Corporation Information
11.5.2 Adama Overview
11.5.3 Adama Polymer Drug Conjugates Sales, Price, Revenue and Gross Margin (2017-2022)
11.5.4 Adama Polymer Drug Conjugates Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Adama Recent Developments
11.6 Eyetech
11.6.1 Eyetech Corporation Information
11.6.2 Eyetech Overview
11.6.3 Eyetech Polymer Drug Conjugates Sales, Price, Revenue and Gross Margin (2017-2022)
11.6.4 Eyetech Polymer Drug Conjugates Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Eyetech Recent Developments
11.7 Ferring
11.7.1 Ferring Corporation Information
11.7.2 Ferring Overview
11.7.3 Ferring Polymer Drug Conjugates Sales, Price, Revenue and Gross Margin (2017-2022)
11.7.4 Ferring Polymer Drug Conjugates Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Ferring Recent Developments
11.8 Flamel Technologies
11.8.1 Flamel Technologies Corporation Information
11.8.2 Flamel Technologies Overview
11.8.3 Flamel Technologies Polymer Drug Conjugates Sales, Price, Revenue and Gross Margin (2017-2022)
11.8.4 Flamel Technologies Polymer Drug Conjugates Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Flamel Technologies Recent Developments
11.9 Genentech
11.9.1 Genentech Corporation Information
11.9.2 Genentech Overview
11.9.3 Genentech Polymer Drug Conjugates Sales, Price, Revenue and Gross Margin (2017-2022)
11.9.4 Genentech Polymer Drug Conjugates Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 Genentech Recent Developments
11.10 GlaxoSmithKline
11.10.1 GlaxoSmithKline Corporation Information
11.10.2 GlaxoSmithKline Overview
11.10.3 GlaxoSmithKline Polymer Drug Conjugates Sales, Price, Revenue and Gross Margin (2017-2022)
11.10.4 GlaxoSmithKline Polymer Drug Conjugates Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 GlaxoSmithKline Recent Developments
11.11 Gowan
11.11.1 Gowan Corporation Information
11.11.2 Gowan Overview
11.11.3 Gowan Polymer Drug Conjugates Sales, Price, Revenue and Gross Margin (2017-2022)
11.11.4 Gowan Polymer Drug Conjugates Product Model Numbers, Pictures, Descriptions and Specifications
11.11.5 Gowan Recent Developments
11.12 Gynecologic Oncology Group Foundation
11.12.1 Gynecologic Oncology Group Foundation Corporation Information
11.12.2 Gynecologic Oncology Group Foundation Overview
11.12.3 Gynecologic Oncology Group Foundation Polymer Drug Conjugates Sales, Price, Revenue and Gross Margin (2017-2022)
11.12.4 Gynecologic Oncology Group Foundation Polymer Drug Conjugates Product Model Numbers, Pictures, Descriptions and Specifications
11.12.5 Gynecologic Oncology Group Foundation Recent Developments
11.13 JenKem Technology
11.13.1 JenKem Technology Corporation Information
11.13.2 JenKem Technology Overview
11.13.3 JenKem Technology Polymer Drug Conjugates Sales, Price, Revenue and Gross Margin (2017-2022)
11.13.4 JenKem Technology Polymer Drug Conjugates Product Model Numbers, Pictures, Descriptions and Specifications
11.13.5 JenKem Technology Recent Developments
11.14 Landec
11.14.1 Landec Corporation Information
11.14.2 Landec Overview
11.14.3 Landec Polymer Drug Conjugates Sales, Price, Revenue and Gross Margin (2017-2022)
11.14.4 Landec Polymer Drug Conjugates Product Model Numbers, Pictures, Descriptions and Specifications
11.14.5 Landec Recent Developments
11.15 Lipotek
11.15.1 Lipotek Corporation Information
11.15.2 Lipotek Overview
11.15.3 Lipotek Polymer Drug Conjugates Sales, Price, Revenue and Gross Margin (2017-2022)
11.15.4 Lipotek Polymer Drug Conjugates Product Model Numbers, Pictures, Descriptions and Specifications
11.15.5 Lipotek Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Polymer Drug Conjugates Industry Chain Analysis
12.2 Polymer Drug Conjugates Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Polymer Drug Conjugates Production Mode & Process
12.4 Polymer Drug Conjugates Sales and Marketing
12.4.1 Polymer Drug Conjugates Sales Channels
12.4.2 Polymer Drug Conjugates Distributors
12.5 Polymer Drug Conjugates Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Polymer Drug Conjugates Industry Trends
13.2 Polymer Drug Conjugates Market Drivers
13.3 Polymer Drug Conjugates Market Challenges
13.4 Polymer Drug Conjugates Market Restraints
14 Key Findings in The Global Polymer Drug Conjugates Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer